Self-interaction of soluble and surface-bound β2-glycoprotein I and its enhancement by lupus anticoagulants

FEBS Letters

Volumn 582, Issue 23-24, 2008, Pages 3308-3312

  Hayashi, Akira ^a   Hayashi, Ayumi ^a   Matsuura, Eiji ^b   Suzuki, Koji ^c   Koike, Takao ^d   Hashimoto, Eikichi ^a   Takeya, Hiroyuki ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 Glycoprotein I; Antiphospholipid; Cardiolipin; Lupus anticoagulant; Phosphatidylserine; Surface plasmon resonance

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BETA2 GLYCOPROTEIN 1; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; IONIC STRENGTH; MOUSE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; HUMANS; LUPUS COAGULATION INHIBITOR; OSMOLAR CONCENTRATION; PHOSPHOLIPIDS; SOLUBILITY; SURFACE PLASMON RESONANCE;

EID: 53049088701     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.09.037     Document Type: Article

References (22)

1. de Laat B., Mertens K., and de Groot P.G. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat. Clin. Pract. Rheumatol. 4 (2008) 192-199
2. 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb. Haemost. 75 (1996) 49-55
3. 2-glycoprotein I monoclonal antibodies. Blood 106 (2005) 1629-1635
4. 2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis 10 (2005) 439-446
5. Matsuura E., Kobayashi K., Tabuchi M., and Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 45 (2006) 466-486
6. 2-glycoprotein I complexes to lipid membranes. Biochemistry 35 (1996) 13833-13842
7. 2GPI binding to phospholipids. J. Clin. Invest. 99 (1997) 2260-2268
8. 2-glycoprotein I complexes on phospholipid surfaces. Thromb. Haemost. 79 (1998) 79-86
9. Giannakopoulos B., Passam F., Rahgozar S., and Krilis S.A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 (2007) 422-430
10. 2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109 (2007) 1490-1494
11. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179 (1994) 457-462
12. 2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood 87 (1996) 3262-3270
13. 2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J. Biol. Chem. 258 (1983) 4765-4770
14. 2-glycoprotein I domain V by heteronuclear magnetic resonance. J. Mol. Biol. 304 (2000) 927-939
15. 2-GP1). Clin. Exp. Immunol. 102 (1995) 373-378
16. Wang S.X., Sun Y.T., and Sui S.F. Membrane-induced conformational change in human apolipoprotein H. Biochem. J. 348 (2000) 103-106
17. 2-glycoprotein I with negatively charged phospholipid membranes. Biochemistry 40 (2001) 14173-14181
18. 2-glycoprotein I revealed by small-angle X-ray scattering. J. Mol. Biol. 321 (2002) 85-97
19. 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood 105 (2005) 1552-1557
20. 2-glycoprotein I only after a conformational change. Blood 107 (2006) 1916-1924
21. 2-GP1). Clin. Exp. Immunol. 102 (1995) 373-378
22. 2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin. Immunol. 112 (2004) 161-168